Literature DB >> 20210701

Proteasome system of protein degradation and processing.

A V Sorokin1, E R Kim, L P Ovchinnikov.   

Abstract

In eukaryotic cells, degradation of most intracellular proteins is realized by proteasomes. The substrates for proteolysis are selected by the fact that the gate to the proteolytic chamber of the proteasome is usually closed, and only proteins carrying a special "label" can get into it. A polyubiquitin chain plays the role of the "label": degradation affects proteins conjugated with a ubiquitin (Ub) chain that consists at minimum of four molecules. Upon entering the proteasome channel, the polypeptide chain of the protein unfolds and stretches along it, being hydrolyzed to short peptides. Ubiquitin per se does not get into the proteasome, but, after destruction of the "labeled" molecule, it is released and labels another molecule. This process has been named "Ub-dependent protein degradation". In this review we systematize current data on the Ub-proteasome system, describe in detail proteasome structure, the ubiquitination system, and the classical ATP/Ub-dependent mechanism of protein degradation, as well as try to focus readers' attention on the existence of alternative mechanisms of proteasomal degradation and processing of proteins. Data on damages of the proteasome system that lead to the development of different diseases are given separately.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20210701     DOI: 10.1134/s000629790913001x

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  60 in total

Review 1.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

2.  Computational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data.

Authors:  Yu-feng Lu; Hao Sheng; Yi Zhang; Zhi-yang Li
Journal:  J Zhejiang Univ Sci B       Date:  2013-09       Impact factor: 3.066

3.  Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspects.

Authors:  Mohammad A Shahshahan; Maureen N Beckley; Ali R Jazirehi
Journal:  Am J Cancer Res       Date:  2011-08-23       Impact factor: 6.166

4.  Relationship between the proteasomal system and autophagy.

Authors:  Alain Lilienbaum
Journal:  Int J Biochem Mol Biol       Date:  2013-03-31

5.  Proteasomal degradation of γ-aminobutyric acidB receptors is mediated by the interaction of the GABAB2 C terminus with the proteasomal ATPase Rtp6 and regulated by neuronal activity.

Authors:  Khaled Zemoura; Dietmar Benke
Journal:  J Biol Chem       Date:  2014-01-30       Impact factor: 5.157

6.  Regulation of the calpain and ubiquitin-proteasome systems in a canine model of muscular dystrophy.

Authors:  Kristine M Wadosky; Luge Li; Jessica E Rodríguez; Jin-Na Min; Dan Bogan; Jason Gonzalez; Cam Patterson; Joe N Kornegay; Monte Willis
Journal:  Muscle Nerve       Date:  2011-08-08       Impact factor: 3.217

7.  Proteasome inhibitor MG132 enhances the antigrowth and antimetastasis effects of radiation in human nonsmall cell lung cancer cells.

Authors:  Jing Liu; Wenhao Shen; Yiting Tang; Jundong Zhou; Ming Li; Wei Zhu; Hongying Yang; Jinchang Wu; Shuyu Zhang; Jianping Cao
Journal:  Tumour Biol       Date:  2014-05-03

Review 8.  Protein degradation systems in platelets.

Authors:  B F Kraemer; A S Weyrich; S Lindemann
Journal:  Thromb Haemost       Date:  2013-09-19       Impact factor: 5.249

9.  LYL1 degradation by the proteasome is directed by a N-terminal PEST rich site in a phosphorylation-independent manner.

Authors:  Georgi L Lukov; Margaret A Goodell
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

10.  Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.

Authors:  Abdel-Rahman Nabawy Zekri; Amira Salah El-Din Youssef; Yasser Mabrouk Bakr; Reham Mohamed Gabr; Ola Sayed Ahmed; Mostafa Hamed Elberry; Ahmed Mahmoud Mayla; Mohamed Abouelhoda; Abeer A Bahnassy
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.